Activity-Guided Isolation of Steroidal Alkaloid Antiestrogen-Binding Site
Inhibitors from Pachysandra procumbens
Leng Chee Chang, Krishna P. L. Bhat, Emily Pisha, Edward J. Kennelly,
²
Harry H. S. Fong,
John M. Pezzuto, and A. Douglas Kinghorn*
Program for Collaborative Research in the Pharmaceutical Sciences and Department of Medicinal Chemistry and
Pharmacognosy, College of Pharmacy, University of Illinois at Chicago, Chicago, Illinois 60612
Received April 24, 1998
Four novel steroidal alkaloids, (+)-(20S)-20-(dimethylamino)-3-(3′R-isopropyl)-lactam-5R-pregn-2-en-4-
one (1), (+)-(20S)-20-(dimethylamino)-16R-hydroxy-3-(3′R-isopropyl)-lactam-5R-pregn-2-en-4-one (2), (+)-
(20S)-3-(benzoylamino)-20-(dimethylamino)-5R-pregn-2-en-4-yl acetate (3), and (+)-(20S)-2R-hydroxy-
20-(dimethylamino)-3-phthalimido-5R-pregnan-4-yl acetate (4), as well as five known compounds, (-)-
pachyaximine A (5), (+)-spiropachysine (6), (+)-axillaridine A (7), (+)-epipachysamine D (8), and (+)-
pachysamine B (9), were isolated from Pachysandra procumbens, using a bioassay-guided fractionation
based on inhibition of
3
H-tamoxifen binding at the antiestrogen binding site (AEBS). Compounds 1-7
and 9 demonstrated significant activity as AEBS-inhibitory agents, and compounds 3, 5 and 9 were found
to potentiate significantly the antiestrogenic effect mediated by tamoxifen in cultured Ishikawa cells.
The structure elucidation of compounds 1-4 was carried out by spectral data interpretation.
Tamoxifen is currently the most widely used antiestro-
genic agent for the therapy of hormone receptor-positive
advanced breast cancer and as an adjuvant treatment in
postmenopausal breast-cancer patients.
1
In addition, in a
recent study conducted with more than 13 000 women at
risk for developing breast cancer, it was concluded that
tamoxifen can reduce the incidence of this disease by
approximately 45%.
2
The mechanism of action has not
been thoroughly delineated, but major effects include both
competition with endogenous estradiol by binding to the
estrogen receptor
3
and blockage of breast-cancer cells in
the G
1
-phase of the cell cycle.
4,5
Apart from binding to the
estrogen receptors, triphenylethylene antiestrogens have
been shown to interact with high affinity and specificity
to the microsomal antiestrogen binding site (AEBS).
6,7
AEBS receptors are found in a wide range of human
tissues
8
and may play an important role in the mechanism
of acquiring resistance to antiestrogen therapy.
9
Cancer chemoprevention can be defined as the preven-
tion, delay, or reversal of cancer by ingestion of dietary or
pharmaceutical agents capable of modulating the process
of carcinogenesis.
10,11
As part of our current work in this
area, a battery of mechanism-based in vitro assays is
employed to facilitate the discovery of potential cancer
chemoprevention agents.
11
As exemplified by tamoxifen,
one method of preventing tumor progression associated
with breast cancer is to exploit the hormone-dependence
of this disease.
11
Accordingly, we have employed the
Ishikawa cell line (an endometrial adenocarcinoma cell
line) to search for new antiestrogens.
12
An ancillary
approach involves the use of compounds that bind specif-
ically to the AEBS,
9
because, in principle, combining such
agents with tamoxifen could elevate the concentration of
this drug available for binding to the estrogen receptor.
9
In this regard, we have examined the potential of test
agents to interact with the AEBS.
Pachysandra is a small genus of four species of shrubs
and perennial herbs. Three species are indigenous to
eastern Asia, occurring in mainland China, Japan, and
Taiwan (P. terminalis Sieb. et Zucc., P. axillaris Franch.,
and P. stylosa Dunn.).
13
P. procumbens Michx. (Buxaceae),
a native American ornamental, is a clump-forming adapt-
able ground-cover plant, valued for its bluish or grayish
green foliage.
14
There have been no previous phytochemi-
cal or biological studies on this species. Several steroidal
(3,20S)-diamino-5R-pregnane alkaloids, however, have been
isolated previously from two related Asian species, P.
terminalis Sieb. et Zucc.
15-19
and P. axillaris Franch.
20-23
In the current investigation, the entire plant of P.
procumbens was chosen for activity-guided fractionation.
The petroleum ether- and ethyl acetate-soluble extracts
were found to exhibit significant activity in an AEBS assay,
as measured by inhibition of
3
H-tamoxifen binding.
24
Four
novel steroidal alkaloids, namely, (+)-(20S)-20-(dimethy-
lamino)-3-(3′R-isopropyl)-lactam-5R-pregn-2-en-4-one (1),
(+)-(20S)-20-(dimethylamino)-16R-hydroxy-3-(3′R-isopro-
pyl)-lactam-5R-pregn-2-en-4-one (2), (+)-(20S)-3-(benzoy-
lamino)-20-(dimethylamino)-5R-pregn-2-en-4-yl acetate (3),
and (+)-(20S)-2R-hydroxy-20-(dimethylamino)-3-phthal-
imido-5R-pregnan-4-yl acetate (4), have been isolated and
characterized structurally. Five known compounds, (-)-
pachyaximine A (5), (+)-spiropachysine (6), (+)-axillaridine
A(7), (+)-epipachysamine D (8), and (+)-pachysamine B
(9), were also isolated. The structure elucidation of 1-4
and the biological evaluation of 1-9 are reported in this
communication.
Results and Discussion
A molecular formula of C
29
H
46
N
2
O
2
was determined from
the HREIMS data (m/z 454.3568) for compound 1. Com-
parison of its UV, IR, and
1
H NMR data with pachyster-
mine A
17
and several more recently isolated analogues
indicated that 1 was a steroidal alkaloid.
20,21,25,26
The
functional groups present in the molecule of 1 could be
assigned as an amide carbonyl (IR, ν
max
1635 cm
-1
; δ
C
169.5), a conjugated ketone (δ
C
196.7), a four-membered
nonfused -lactam ring (IR, ν
max
1732 cm
-1
), and a gem-
dimethyl group (ν
max
1336-1231 cm
-1
; δ
C
20.1, 19.9; δ
H
1.06, 0.96). The
1
H and
13
C NMR data for the -lactam
moiety [δ
C
169.5, δ
C
57.8; δ
H
3.00, δ
C
46.5; δ
H
3.40 and 4.00]
* Address reprint requests to A. D. Kinghorn. Tel.: (312) 996-0914.
Fax: (312) 996-7107. E-mail Kinghorn@uic.edu.
²
Present address: U.S. Food and Drug Administration, Center for Food
and Nutrition, Office of Special Nutritionals, HFS-465, 200 C Street NW,
Washington, DC 20204.
1257 J. Nat. Prod. 1998, 61, 1257-1262
10.1021/np980162x CCC: $15.00 © 1998 American Chemical Society and American Society of Pharmacognosy
Published on Web 09/10/1998